v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Income Statement [Abstract]        
Revenue $ 336,041 $ 341,906 $ 674,845 $ 696,549
Cost of Sales (excluding depreciation and amortization) 64,784 109,616 131,204 217,174
Gross Profit 271,257 232,290 543,641 479,375
Operating Expenses        
Sales and marketing expenses 188,986 56,622 385,558 78,667
General and administrative expenses 1,056,512 565,849 2,403,956 1,113,088
Research and development expenses 73,172 131,119
Total operating expenses 1,318,670 622,471 2,920,633 1,191,755
Other Income        
Interest income 6,449 31,754
Other income, net 12,000 19,037
Total Other Income 18,449 50,791
Loss before provision for income taxes (1,028,964) (390,181) (2,326,201) (712,380)
Income tax benefit (expense), net
Net loss (1,028,964) (390,181) (2,326,201) (712,380)
Comprehensive loss $ (1,028,964) $ (390,181) $ (2,326,201) $ (712,380)
Net loss per share - Basic [1] $ (0.08) $ (0.04) $ (0.19) $ (0.07)
Net loss per share - Diluted [1] $ (0.08) $ (0.04) $ (0.19) $ (0.07)
Weighted average number of shares outstanding - Basic [1] 12,144,730 10,031,273 12,131,202 10,031,273
Weighted average number of shares outstanding - Diluted [1] 12,144,730 10,031,273 12,131,202 10,031,273
[1] Shares and per share data are presented on a retroactive basis to reflect a 1.2-for-1 reverse stock split of the common stock which occurred on January 15, 2025. See Note 6(B).